Log has written
SUNDAY, NOVEMBER 29, 2009 2:22 AM IST
Intas Pharma may offload 10% to raise Rs200 cr from market
The drug maker, which is ranked 16th in the Rs34,000 crore Indian domestic market, will dilute about 10% in the initial public offer (IPO)
Read The Article
Add your Comment
  • Please use English to post and reply to comments
  • Please do not use offensive language in the form of racial or ethnic slurs, abuse or personal insults
  • We welcome opinion and debate geared towards finding solutions
  • Please keep comments relevant to the topic
First Name*
Last Name*
Email*
Comments*
Maximum characters allowed-2000
Enter code*
Disclaimer
All the content posted in this category are made by the readers of livemint unless specified otherwise. Livemint is not responsible for the opinions of the readers and the content posted by the readers are not respresentative of the views and opinions of livemint.
Copyright © 2009 HT Media All Rights Reserved